Dr. Jay H. Stone, MD

Dr. Stone practices at Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey.

Dr. Stone's NPI, 1710961024, was assigned on November 30, 2005. Dr. Stone holds New Jersey license MA04961200.

Dr. Stone's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD, at 200 S Orange Ave, Livingston, NJ 07039.

Dr. Stone's primary practice is Saint Barnabas Rcg Dialysis Center-Livingston - HOPD in Livingston, New Jersey. Dr. Stone is also affiliated with Community Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Stone to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stone practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Stone's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Stone is licensed in New Jersey.

CMS data shows 3,206 Medicare services from Dr. Stone across 18 procedure codes in 2024, for 1,555 Medicare patients. Medicare paid $188,935 for them.

CMS counts 1,555 Medicare patients who saw Dr. Stone in 2024. The largest group is 75 to 84, with 598 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stone's median patient age at 76, with 43% women.

In 2024, Dr. Stone wrote 3,225 Medicare Part D claims for 898 patients. 83% of them were for generic drugs. CMS names the drug for 2,995 of them, across 39 drugs with 11 or more claims each, at $620,574 in total drug cost. In 2023, CMS named 2,591 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Stone for performance year 2024, reported through an alternative payment model (APM). Dr. Stone accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of coronary angioplasty and stenting by Dr. Stone, more than 50% of the clinicians it reports for that procedure.

CMS Open Payments shows 1,317 general payments to Dr. Stone from 66 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Bristol-Myers Squibb Company paid the most, $59,875.